Postnatal corticosteroids for transient tachypnoea of the newborn.

CONCLUSIONS: Given the paucity and very low quality of the available evidence, we are unable to determine the benefits and harms of postnatal administration of either inhaled or systemic corticosteroids for the management of TTN. PMID: 32180216 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/32180216?dopt=Abstract

Source: Cochrane Database of Systematic Reviews - March 16, 2020 Category: General Medicine Authors: Bruschettini M, Moresco L, Calevo MG, Romantsik O Tags: Cochrane Database Syst Rev Source Type: research